Girard Sharp has filed a complaint against pharmaceutical companies AbbVie and Amgen alleging the companies engaged in anticompetitive practices with respect to the biologic drug Humira. Plaintiff Fraternal Order of Police Miami Lodge 20 Insurance Trust Fund, on behalf of itself and a proposed class of Humira purchasers, alleges that AbbVie has created a “thicket” of over 100 patents to frustrate other companies’ efforts to sell competing versions of Humira, and that AbbVie colluded with Amgen to keep Amgen’s product off the market, resulting in continued high prices for Humira.
